Gainers
- LogicMark LGMK stock rose 61.6% to $0.21 during Tuesday's pre-market session. The company's market cap stands at $2.5 million. As per the news, the Q3 earnings report came out today.
- CERo Therapeutics Hldgs CERO shares increased by 46.12% to $0.29. The market value of their outstanding shares is at $43.0 million.
- Nevro NVRO shares increased by 28.75% to $6.85. The market value of their outstanding shares is at $255.3 million. As per the press release, Q3 earnings came out yesterday.
- CareCloud CCLDP shares rose 28.17% to $15.97.
- Taysha Gene Therapies TSHA shares rose 27.56% to $2.08. The company's market cap stands at $426.1 million.
- CareCloud CCLD shares moved upwards by 22.6% to $3.2. The market value of their outstanding shares is at $51.8 million. As per the press release, Q3 earnings came out today.
Losers
- Heron Therapeutics HRTX stock decreased by 40.2% to $1.1 during Tuesday's pre-market session. The market value of their outstanding shares is at $166.8 million. As per the press release, Q3 earnings came out today.
- Neurogene NGNE stock decreased by 31.36% to $49.1. The company's market cap stands at $728.0 million.
- Neuronetics STIM shares declined by 27.28% to $0.8. The market value of their outstanding shares is at $24.2 million. The company's, Q3 earnings came out today.
- Rockwell Medical RMTI shares decreased by 25.81% to $3.45. The market value of their outstanding shares is at $107.0 million. The company's, Q3 earnings came out today.
- Syndax Pharmaceuticals SNDX stock fell 25.3% to $16.27. The market value of their outstanding shares is at $1.3 billion.
- Quantum-Si QSI shares declined by 18.4% to $0.82. The market value of their outstanding shares is at $116.1 million. As per the press release, Q3 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in